tm logo
TEBGLYSS
Filing date accorded

on 22 Oct 2024

Last Applicant/ Owned by

Eli Lilly and Company

Lilly Corporate CenterIndianapolis, IN 46285

US

Serial Number

2200247 filed on 26th Jul 2022

Correspondent Address

World Exchange Plaza100 Queen Street, Suite 1300Ottawa

ONTARIO

CA

K1P1J9

TEBGLYSS

Trademark usage description

pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of alopecia, alzheimer's disease, atopic dermatitis, autoimmune dis Read More

Classification Information


Class [005]
Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of alopecia, Alzheimer's disease, atopic dermatitis, autoimmune diseases and disorders, blood diseases and disorders, bone and skeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, cluster headaches, Coronavirus disease, Crohn's disease, dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, fibromyalgia, gastrointestinal diseases and disorders, headaches, heart failure, inflammation and inflammatory diseases and disorders, inflammatory bowel disease, kidney diseases and disorders, liver diseases and disorders, lupus, mental disorders, metabolic diseases and disorders, migraines, multiple sclerosis, neurodegenerative diseases and disorders, neurological disorders, obesity, osteoarthritis, pain, Parkinson's disease, Psoriasis, Psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, vascular diseases


Classification kind code

11

Mark Details


Serial Number

2200247

Mark Type

Trademark

Legal History


Action TakenStatus
Submitted for opposition 22
on 22nd Oct 2024
Search Recorded
Submitted for opposition 20
on 22nd Oct 2024
Examiner's First Report
Submitted for opposition 287
on 04th Aug 2022
Pre-Assessment Letter Sent
Submitted for opposition 30
on 26th Jul 2022
Filed
Submitted for opposition 1
on 26th Jul 2022
Created
Submitted for opposition 31
on 26th Jul 2022
Formalized